How has the flowable hemostats market evolved, and where is it heading next?
The flowable hemostats market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth in elective surgeries, rising adoption of personalized medicine, increased healthcare spending, and expansion of healthcare infrastructure in emerging markets.
The flowable hemostats market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the increasing number of surgical procedures, rising prevalence of chronic diseases, growing demand for minimally invasive surgeries, and an expanding geriatric population requiring surgical care. Major trends in the forecast period include integration of advanced bioengineered materials, development of smart hemostatic products, robotic-assisted and minimally invasive surgical techniques, adoption of patient-specific and personalized hemostatic solutions, and advanced customization of hemostats.
Get Your Free Sample of The Global Flowable Hemostats Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp
What are the key drivers behind the rapid expansion of the flowable hemostats market?
An increasing number of surgical procedures is expected to propel the growth of the flowable hemostats market going forward. The number of surgical procedures is increasing due to an aging population, which drives demand for age-related surgeries, and technological advancements that have made surgeries safer and more accessible. Flowable hemostats are highly useful in surgical procedures as it helps in control bleeding in areas that are difficult to access or where traditional methods may not be effective. For instance, in June 2024, according to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, in 2023, the total number of surgical and non-surgical procedures rose by 3.4%, reaching 34.9 million, compared to the previous year. Therefore, the increasing number of surgical procedures is driving the growth of the flowable hemostats market.
What is the segmentation for the flowable hemostats market?
The flowable hemostats market covered in this report is segmented –
1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats
2) By Material: Porcine Gelatin, Bovine Gelatin
3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications
4) By End User: Hospital And Clinics, Ambulatory Surgery Centers
Subsegments:
1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats
2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats
3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report
Who are the most influential companies in the flowable hemostats market?
Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.
What are the most influential trends expected to drive the flowable hemostats market forward?
Major companies operating in the flowable hemostats market are focusing on developing surgically advanced hemostatic agents, such as no-swell technology, to address the evolving needs of surgical procedures. No-swell technology refers to a property of a hemostatic agent that prevents it from absorbing fluids and expanding, making it suitable for use in surgeries where swelling could cause complications. For instance, in January 2023, Medcura Inc., a US-based surgical technology platform, received Food and Drug Administration (FDA) breakthrough device designation for its LifeGel flowable technology that controls bleeding during surgery for procedures where swelling cannot be tolerated. Medcura’s LifeGel is the first and only flowable hemostatic gel designed to address challenges specific to hemostatic swelling. The absorbable agent does not swell as it is fully hydrated and ready-to-use, potentially mitigating risks associated with swelling, such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, relatively transparent, and mucoadheres to tissues, offering a safer and more effective solution for controlling bleeding during complex surgical procedures.
What are the major regional insights for the flowable hemostats market, and which region holds the top position?
North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Flowable Hemostats Market Report 2025 Offer?
The flowable hemostats market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Flowable hemostats are gelatinous medical devices used to control bleeding during surgery, conforming to irregular wound shapes for effective application. They promote clotting by forming a physical barrier and activating the body’s coagulation cascade, making them ideal for complex or delicate surgical areas.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20552
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
